Paloma Partners Management CO Edwards Lifesciences Corp Put Options Transaction History

Paloma Partners Management CO

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $3.1 Million - $4.87 Million	51,900 New	51,900 $3.42 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $2.5 Million - $3.15 Million	40,500 Added 397.06%	50,700 $3.87 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $706,656 - $952,476	10,200 New	10,200 $706,000
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $1.57 Million - $1.79 Million	-21,200 Reduced 81.23%	4,900 $405,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $129,770 - $166,136	-1,900 Reduced 6.79%	26,100 $1.95 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $2.31 Million - $3 Million	28,000 New	28,000 $2.31 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $51,050 - $62,634	-1,100 Reduced 17.74%	5,100 $781,000
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $209,498 - $244,218	6,200	6,200 $699,000

1,350

456M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.